Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C2 | P08235 | 7/20 | 0.69 |
| ▸ | PGR | P06401 | 4/20 | 0.69 |
| ▸ | NR3C1 | P04150 | 4/20 | 0.69 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | AR | P10275 | 3/20 | 0.60 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | MLNR | O43193 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.53 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.53 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL122186 | 0.93 | NR3C2 (0.79) | NR3C2PGRNR3C1HIF1AKMT2A | |
| SCHEMBL1807730 | 0.92 | PGR (0.68) | NR3C2PGRNR3C1HIF1AKMT2A | |
| SCHEMBL1807731 | 0.90 | PGR (0.70) | NR3C2PGRNR3C1HIF1AKMT2A | |
| Butixocort SCHEMBL23803956 | 0.89 | NR3C2 (0.86) | NR3C2PGRNR3C1HIF1AKMT2A | |
| Butixocort SCHEMBL109157 | 0.89 | NR3C2 (0.86) | NR3C2PGRNR3C1HIF1AKMT2A | |
| SCHEMBL23803941 | 0.85 | HIF1A (0.60) | NR3C2PGRNR3C1HIF1AKMT2A | |
| Resocortol Butyrate SCHEMBL2110603 | 0.84 | NR3C2 (0.89) | NR3C2PGRNR3C1HIF1AKMT2A | |
| SCHEMBL23456329 | 0.83 | NR3C2 (0.70) | NR3C2PGRNR3C1HIF1AKMT2A | |
| SCHEMBL10535271 | 0.82 | NR3C2 (0.80) | NR3C2PGRNR3C1HIF1AKMT2A | |
| SCHEMBL11581184 | 0.82 | NR3C2 (0.89) | NR3C2PGRNR3C1HIF1AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2776 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260130899-A1 | METHOD OF TREATMENT FOR PREVENTION OF GLUCOCORTICOID TOXICITY AND/OR ENHANCEMENT OF MUSCLE REGENERATION VIA NEUTROPHIL ELASTASE INHIBITION | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2026-05-14 | — | — | US | claimed |
| EP-4126138-B1 | AEROSOL DELIVERY OF AT LEAST TWO LIQUID COMPOSITIONS | INVOX BELGIUM NV (BE) | 2024-10-16 | — | — | EP | claimed |
| US-20240216353-A1 | METHOD OF TREATMENT FOR PREVENTION OF GLUCOCORTICOID TOXICITY AND/OR ENHANCEMENT OF MUSCLE REGENERATION VIA NEUTROPHIL ELASTASE INHIBITION | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2024-07-04 | — | — | US | claimed |
| EP-4126138-A1 | AEROSOL DELIVERY OF AT LEAST TWO LIQUID COMPOSITIONS | Softhale NV (BE) | 2023-02-08 | — | — | EP | claimed |
| US-20220096498-A1 | INJECTABLE SUSTAINED-RELEASE FORMULATIONS FOR TREATMENT OF JOINT PAIN AND INFLAMMATION | FORDOZ PHARMA CORP. (US) | 2022-03-31 | — | — | US | claimed |
| US-11247969-B2 | Biphenyl compounds useful as muscarinic receptor antagonists | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2022-02-15 | — | — | US | claimed |
| US-20210315873-A1 | METHOD OF TREATMENT FOR PREVENTION OF GLUCOCORTICOID TOXICITY AND/OR ENHANCEMENT OF MUSCLE REGENERATION VIA NEUTROPHIL ELASTASE INHIBITION | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2021-10-14 | — | — | US | claimed |
| WO-2021198154-A1 | AEROSOL DELIVERY OF AT LEAST TWO LIQUID COMPOSITIONS | SOFTHALE NV (BE) | 2021-10-07 | — | — | WO | claimed |
| US-10919934-B2 | Compositions and methods for managing respiratory conditions | EMORY UNIVERSITY (US) | 2021-02-16 | — | — | US | claimed |
| WO-2020227353-A1 | INJECTABLE SUSTAINED-RELEASE FORMULATIONS FOR TREATMENT OF JOINT PAIN AND INFLAMMATION | FORDOZ PHARMA CORP. (US) | 2020-11-12 | — | — | WO | claimed |
| EP-1341542-A2 | ORGANIC COMPOUNDS | Novartis AG (CH) | 2003-09-10 | — | — | EP | claimed |
| US-20020164290-A1 | Biocompatible compounds for sustained release pharmaceutical drug delivery systems | 3M INNOVATIVE PROPERTIES COMPANY | 2002-11-07 | — | — | US | claimed |
| US-6416742-B1 | DISSOLVED POLYLACTONE, POLYTHIOESTER, OR POLYLACTAM AND FLUOROCARBON PROPELLANT; BIODEGRADABLE POLYMER STABILIZES AND SOLUBILIZES THE DRUG; SUSTAINED RELEASE | 3M INNOVATIVE PROPERTIES COMPANY | 2002-07-09 | — | — | US | claimed |
| WO-2002045703-A2 | MIXTURES OR ORGANIC COMPOUNDS FOR THE TREATMENTOF AIRWAY DISEASES | NOVARTIS AG (CH) | 2002-06-13 | — | — | WO | claimed |
| US-6126919-A | METERED DOSE INHALER FOR SUSTAINED RELEASE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-10-03 | — | — | US | claimed |
| EP-1014944-A2 | BIOCOMPATIBLE COMPOUNDS FOR PHARMACEUTICAL DRUG DELIVERY SYSTEMS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 2000-07-05 | — | — | EP | claimed |
| WO-1998034596-A2 | BIOCOMPATIBLE COMPOUNDS FOR PHARMACEUTICAL DRUG DELIVERY SYSTEMS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-08-13 | — | — | WO | claimed |
| EP-0817611-A1 | BUTIXOCORT AEROSOL FORMULATIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-01-14 | — | — | EP | claimed |
| US-5653961-A | SOLUTION COMPRISING NON-OZONE DEPLETING 1,1,1,2-TETRAFLUOROETHANE AND/OR 1,1,1,2,3,3,3-HEPTAFLUOROPROPANE; BRONCHIAL ASTHMA; STORAGE STABILITY | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-08-05 | — | — | US | claimed |
| WO-1996029985-A1 | BUTIXOCORT AEROSOL FORMULATIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-10-03 | — | — | WO | claimed |